The 1‑year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study.

Neth Heart J · 2019 · PMC6823340 · PMID 31197750

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

Finally, in a multivariate Cox regression analysis adjusting for age, gender and PCI indication, insulin-treated DM was the only variable that showed a trend toward predicting MACE (HR 2.76; 95% CI: 0.94–8.07; p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.